Address challenges to oncology medication used as off-label drugs.
Discuss how to ethically reject medication to a patient without another choice of treatment.
List the current rules and regulations regarding e-Prescribing for controlled submstances and what is the potential impact.
What questions have arisen in your practice for which you need answers/strategies that you can implement?
Are you interested in basic, intermediate or advanced level trainings?
What barriers might you have that would interfere with implementation of new information learned from this training?
How can this training be improved to better impact competence, performance and/or patient outcomes?
Additional comments: